Category:
Media Reports about Drug-Resistant Infections
Author – Arjun Srinivasan, MD CDC’s Division of Healthcare Quality Promotion You probably have seen the media reports this week about drug-resistant infections in California healthcare facilities, specifically those in Los Angeles County. What we know, however, is that carbapenem-resistant Klebsiella pneumoniae (CRKP) actually exists in at least 36 states. Originally identified in 1999, CRKP Read More >
Posted on by 2 CommentsNew Clinical Guidelines for MRSA Treatment
Author – Dr. Catherine Liu Assistant Clinical Professor, Division of Infectious Diseases, University of California Methicillin-resistant Staphylococcus aureus (MRSA) – both healthcare- and community-associated – has become an enormous public health problem. MRSA is responsible for about 60 percent of skin and soft tissue infections seen in emergency rooms, and invasive MRSA kills about 18,000 Read More >
Posted on by 7 Comments$10 Million Dollars to Save Countless Lives
Author – John Jernigan, M.D. CDC’s Division of Healthcare Quality Promotion Today, I am proud to announce that my office is awarding $10 million for new research to five academic medical centers as part of our Prevention Epicenter grant program. This program supports efforts to develop and test innovative approaches to reducing infections in healthcare Read More >
Posted on by 1 CommentInfections in ICUs Plummeting, Too Many Remain in Hospitals and Dialysis Clinics
Author – Arjun Srinivasan, MD CDC’s Division of Healthcare Quality Promotion As you know, bloodstream infections in patients with central lines can be deadly, killing as many as 1 in 4 patients who gets them. The newest edition of the CDC Vital Signs reports a major decrease in central-line associated bloodstream infections (CLABSIs) in intensive Read More >
Posted on by 4 CommentsDr. Peter Pronovost on CDC’s Vital Signs Report: Why Success was Possible
Dr. Peter Pronovost, Johns Hopkins University, provides three video commentaries on CDC’s recent Vital Signs report on central line-associated bloodstream infections in hospitals and dialysis facilities. Dr. Pronovost’s commentary is provided below. Click on the video to watch Transcript: Why was success possible? Success was possible because many groups partnered and worked collaboratively. On the Read More >
Posted on by 1 Comment